An improved model of the Aspergillus fumigatus CYP51A protein

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2483-2486

  Fraczek, M G ^a   Bromley, M ^a   Bowyer, P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 51A; FLUCONAZOLE; FUNGAL PROTEIN; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLUS FUMIGATUS; CHEMICAL MODEL; DNA SEQUENCE; DRUG STRUCTURE; GENE MUTATION; NONHUMAN; ORTHOLOGY; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; MOLECULAR STRUCTURE;

EID: 79955528419     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01651-10     Document Type: Article

References (15)

1. Bellamine, A., A. T. Mangla, W. D. Nes, and M. R. Waterman. 1999. Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 96:8937-8942.
2. Benkert, P., S. C. Tosatto, and D. Schomburg. 2008. QMEAN: a comprehensive scoring function for model quality assessment. Proteins 71:261-277. (Pubitemid 351358609)
3. Benkert, P., M. Kunzli, and T. Schwede. 2009. QMEAN server for protein model quality estimation. Nucleic Acids Res. 37:W510-W514.
4. Bueid, A., et al. 2010. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J. Antimicrob. Chemother. 65:2116-2118.
5. Cools, H. J., B. A. Fraaije, S. H. Kim, and J. A. Lucas. 2006. Impact of changes in the target P450 CYP51 enzyme associated with altered triazole-sensitivity in fungal pathogens of cereal crops. Biochem. Soc. Trans. 34:1219-1222.
6. Cools, H. J., and B. A. Fraaije. 2008. Are azole fungicides losing ground against Septoria wheat disease? Resistance mechanisms in Mycosphaerella graminicola. Pest Manag. Sci. 64:681-684.
7. Eswar, N., et al. 2007. Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 50:2.9.1-2.9.31.
8. Howard, S. J., et al. 2009. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg. Infect. Dis. 15:1068-1076.
9. Kelly, S. L., D. C. Lamb, C. J. Jackson, A. G. Warrilow, and D. E. Kelly. 2003. The biodiversity of microbial cytochromes P450. Adv. Microb. Physiol. 47:131-186.
10. Lass-Florl, C. 2009. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 52:197-205.
11. Mellado, E., et al. 2007. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob. Agents Chemother. 51:1897-1904.
12. Podust, L. M., T. L. Poulos, and M. R. Waterman. 2001. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98:3068-3073.
13. Snelders, E., A. Karawajczyk, G. Schaftenaar, P. E. Verweij, and W. J. Melchers. 2010. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob. Agents Chemother. 54:2425-2430.
14. Snelders, E., et al. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 5:e219.
15. Xiao, L., et al. 2004. Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding. Antimicrob. Agents Chemother. 48:568-574.